AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-31819250_ITM" title="Facts and information about FDA approves new schizophrenia drug.(Invega)(Brief article)">FDA approves new schizophrenia drug.(Invega)(Brief article)</a>

Close Set up an RSS feed that alerts you when new articles from Mental Health Weekly are available.

Frequently asked questions about RSS feeds

FDA approves new schizophrenia drug.(Invega)(Brief article)

Mental Health Weekly

| January 08, 2007 | This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

The first new treatment for schizophrenia to be approved since 2003, the atypical antipsychotic Invega (paliperidone) extended-release, was approved by the U.S. Food and Drug Administration on December 20. Janssen, L.P., which will market the drug, reported that Invega is the first oral extended release treatment, in which OROS [R] extended-release technology allows…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


Johnson and Johnson schizophrenia drug wins U.S. government approval.: News wire article from: The America's Intelligence Wire December 20, 2006 700+ words
...OLEKSYN A Johnson and Johnson schizophrenia drug derived from a medicine that...and Drug Administration said Invega adds to the treatment options...affects millions of people. Invega, also called paliperidone...data company IMS Health. Invega could become an important...


INVEGA(TM) Receives Marketing Authorization In European Union For Treatment Of...: Press release article from: PR Newswire June 28, 2007 700+ words
...Commission granted marketing authorization for INVEGA(TM) (paliperidone prolonged release...paliperidone - the active ingredient in INVEGA - through the innovative osmotic delivery...OROS(R)). In clinical trials, INVEGA demonstrated significant efficacy as compared...


INVEGA(TM) Approved By FDA as New Treatment for Schizophrenia.: Press release article from: PR Newswire December 20, 2006 700+ words
...Drug Administration (FDA) has approved INVEGA(TM) (paliperidone) Extended-Release...proven safety and tolerability profile. INVEGA will be marketed by Janssen, L.P...23 countries, have demonstrated that INVEGA provided significant improvement in multiple...


INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of...: Press release article from: PR Newswire December 12, 2007 700+ words
...N.J., Dec. 12 /PRNewswire/ -- INVEGA(TM) (paliperidone) Extended-Release...to evaluate the long-term safety of INVEGA, an oral, atypical anti-psychotic...patients that transitioned from placebo to INVEGA and were maintained in those that were...


INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to...: Press release article from: PR Newswire October 13, 2007 700+ words
...significant improvement in symptoms after taking INVEGA(TM) (paliperidone) Extended-Release...Symptom improvement was observed with INVEGA as early as five days into therapy and...of the study. The results showed that INVEGA achieved a significant reduction of symptoms...


FDA Approves INVEGA (TM) for Long-Term Maintenance Treatment of Schizophrenia.: Press release article from: PR Newswire April 27, 2007 700+ words
...Administration (FDA) today approved INVEGA(TM) (paliperidone) Extended-Release...maintenance treatment of schizophrenia. INVEGA is now indicated for both acute (short...schizophrenia. The agency's latest approval for INVEGA is based on a long-term efficacy study...


Study Suggests INVEGA(TM) Helps Patients With Schizophrenia Maintain Symptom...: Press release article from: PR Newswire March 30, 2007 700+ words
...PRNewswire/ -- Longer-term treatment with INVEGA(TM) (paliperidone) Extended-Release...Janssen, L.P., the U.S. marketer of INVEGA, and were presented today at the International...on Schizophrenia Research (ICOSR). INVEGA was approved last December by the U...


Topline Findings from Comparative Analysis of INVEGA(TM) and Quetiapine in...: Press release article from: PR Newswire October 8, 2007 700+ words
...results from a clinical study comparing INVEGA(TM) (paliperidone) Extended-Release...Palms Resort & Convention Center. INVEGA is an atypical antipsychotic medication...schizophrenia. Janssen, L.P, markets INVEGA in the U.S. IMPORTANT SAFETY INFORMATION...


Invega signficantly cuts schizophrenia vs Seroquel.: Newspaper article from: Pharma Marketletter October 22, 2007 700+ words
...a Johnson & Johnson company) Invega (paliperidone) extended-release tablets...Symptom improvement was observed with Invega as early as five days into therapy and...of the study. The results showed that Invega achieved a significant reduction of symptoms...


Janssen, L.P. Selects INVEGA(TM) (paliperidone) Extended Release tablets as...: Press release article from: PR Newswire November 10, 2006 700+ words
...Johnson, announced that it has selected INVEGA(TM) as the brand name for paliperidone...Drug Administration (FDA) to market INVEGA(TM) for the treatment of schizophrenia...class 1 (i.e., two month) review for INVEGA(TM). The new user fee goal date for...

For more facts and information, see all results

The AccessMyLibrary advertising network includes: